Oligomerization of G-protein-coupled transmitter receptors - PubMed

Review

Oligomerization of G-protein-coupled transmitter receptors

M Bouvier. Nat Rev Neurosci. 2001 Apr.

Abstract

Examples of G-protein-coupled receptors that can be biochemically detected in homo- or heteromeric complexes are emerging at an accelerated rate. Biophysical approaches have confirmed the existence of several such complexes in living cells and there is strong evidence to support the idea that dimerization is important in different aspects of receptor biogenesis and function. While the existence of G-protein-coupled-receptor homodimers raises fundamental questions about the molecular mechanisms involved in transmitter recognition and signal transduction, the formation of heterodimers raises fascinating combinatorial possibilities that could underlie an unexpected level of pharmacological diversity, and contribute to cross-talk regulation between transmission systems. Because G-protein-coupled receptors are major pharmacological targets, the existence of dimers could have important implications for the development and screening of new drugs. Here, we review the evidence supporting the existence of G-protein-coupled-receptor dimerization and discuss its functional importance.

Similar articles

• Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons.

  Agnati LF, Ferré S, Lluis C, Franco R, Fuxe K. Agnati LF, et al. Pharmacol Rev. 2003 Sep;55(3):509-50. doi: 10.1124/pr.55.3.2. Epub 2003 Jul 17. Pharmacol Rev. 2003. PMID: 12869660 Review.

• G protein-coupled receptor oligomerization: implications for G protein activation and cell signaling.

  Breitwieser GE. Breitwieser GE. Circ Res. 2004 Jan 9;94(1):17-27. doi: 10.1161/01.RES.0000110420.68526.19. Circ Res. 2004. PMID: 14715532 Review.

• Dimerization and oligomerization of G-protein-coupled receptors: debated structures with established and emerging functions.

  Szidonya L, Cserzo M, Hunyady L. Szidonya L, et al. J Endocrinol. 2008 Mar;196(3):435-53. doi: 10.1677/JOE-07-0573. J Endocrinol. 2008. PMID: 18310440 Review.

• Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function.

  Angers S, Salahpour A, Bouvier M. Angers S, et al. Annu Rev Pharmacol Toxicol. 2002;42:409-35. doi: 10.1146/annurev.pharmtox.42.091701.082314. Annu Rev Pharmacol Toxicol. 2002. PMID: 11807178 Review.

• Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity.

  Urizar E, Montanelli L, Loy T, Bonomi M, Swillens S, Gales C, Bouvier M, Smits G, Vassart G, Costagliola S. Urizar E, et al. EMBO J. 2005 Jun 1;24(11):1954-64. doi: 10.1038/sj.emboj.7600686. Epub 2005 May 12. EMBO J. 2005. PMID: 15889138 Free PMC article.

Cited by

• Distinct roles of metabotropic glutamate receptor dimerization in agonist activation and G-protein coupling.

  El Moustaine D, Granier S, Doumazane E, Scholler P, Rahmeh R, Bron P, Mouillac B, Banères JL, Rondard P, Pin JP. El Moustaine D, et al. Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16342-7. doi: 10.1073/pnas.1205838109. Epub 2012 Sep 17. Proc Natl Acad Sci U S A. 2012. PMID: 22988116 Free PMC article.

• Biogenic amines and the control of neuromuscular signaling in schistosomes.

  Ribeiro P, Gupta V, El-Sakkary N. Ribeiro P, et al. Invert Neurosci. 2012 Jun;12(1):13-28. doi: 10.1007/s10158-012-0132-y. Epub 2012 Apr 18. Invert Neurosci. 2012. PMID: 22526557 Review.

• Intramembrane receptor-receptor interactions: a novel principle in molecular medicine.

  Fuxe K, Canals M, Torvinen M, Marcellino D, Terasmaa A, Genedani S, Leo G, Guidolin D, Diaz-Cabiale Z, Rivera A, Lundstrom L, Langel U, Narvaez J, Tanganelli S, Lluis C, Ferré S, Woods A, Franco R, Agnati LF. Fuxe K, et al. J Neural Transm (Vienna). 2007 Jan;114(1):49-75. doi: 10.1007/s00702-006-0589-0. Epub 2006 Oct 27. J Neural Transm (Vienna). 2007. PMID: 17066251 Review.

• Receptor-activity-modifying proteins are required for forward trafficking of the calcium-sensing receptor to the plasma membrane.

  Bouschet T, Martin S, Henley JM. Bouschet T, et al. J Cell Sci. 2005 Oct 15;118(Pt 20):4709-20. doi: 10.1242/jcs.02598. Epub 2005 Sep 27. J Cell Sci. 2005. PMID: 16188935 Free PMC article.

• A heterozygous mutation in the third transmembrane domain causes a dominant-negative effect on signalling capability of the MC4R.

  Tarnow P, Rediger A, Brumm H, Ambrugger P, Rettenbacher E, Widhalm K, Hinney A, Kleinau G, Schaefer M, Hebebrand J, Krause G, Grüters A, Biebermann H. Tarnow P, et al. Obes Facts. 2008;1(3):155-62. doi: 10.1159/000138251. Epub 2008 Jun 20. Obes Facts. 2008. PMID: 20054175 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database